India
· Delayed Price · Currency is INR Sun Pharmaceutical Industries Statistics
Total Valuation
Sun Pharmaceutical Industries has a market cap or net worth of INR 4.34 trillion. The enterprise value is 4.17 trillion.
| Market Cap | 4.34T |
| Enterprise Value | 4.17T |
Important Dates
The next estimated earnings date is Monday, January 27, 2025.
| Earnings Date | Jan 27, 2025 |
| Ex-Dividend Date | Jul 12, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 39.26.
| PE Ratio | 39.26 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 8.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.94, with an EV/FCF ratio of 38.68.
| EV / Earnings | 37.70 |
| EV / Sales | 8.28 |
| EV / EBITDA | 29.94 |
| EV / EBIT | 36.46 |
| EV / FCF | 38.68 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.67 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.24 |
| Interest Coverage | 47.90 |
Financial Efficiency
Return on equity (ROE) is 16.77% and return on invested capital (ROIC) is 10.44%.
| Return on Equity (ROE) | 16.77% |
| Return on Assets (ROA) | 8.54% |
| Return on Capital (ROIC) | 10.44% |
| Revenue Per Employee | 11.70M |
| Profits Per Employee | 2.57M |
| Employee Count | 43,000 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +45.20% |
| 50-Day Moving Average | 1,823.48 |
| 200-Day Moving Average | 1,682.24 |
| Relative Strength Index (RSI) | 50.72 |
| Average Volume (20 Days) | 48,609 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sun Pharmaceutical Industries had revenue of INR 503.08 billion and earned 110.54 billion in profits. Earnings per share was 46.11.
| Revenue | 503.08B |
| Gross Profit | 390.41B |
| Operating Income | 114.49B |
| Pretax Income | 128.18B |
| Net Income | 110.54B |
| EBITDA | 138.02B |
| EBIT | 114.49B |
| Earnings Per Share (EPS) | 46.11 |
Balance Sheet
The company has 201.22 billion in cash and 25.72 billion in debt, giving a net cash position of 175.50 billion.
| Cash & Cash Equivalents | 201.22B |
| Total Debt | 25.72B |
| Net Cash | 175.50B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 693.80B |
| Book Value Per Share | 288.72 |
| Working Capital | 288.50B |
Cash Flow
In the last 12 months, operating cash flow was 127.15 billion and capital expenditures -19.42 billion, giving a free cash flow of 107.74 billion.
| Operating Cash Flow | 127.15B |
| Capital Expenditures | -19.42B |
| Free Cash Flow | 107.74B |
| FCF Per Share | n/a |
Margins
Gross margin is 77.60%, with operating and profit margins of 22.76% and 21.97%.
| Gross Margin | 77.60% |
| Operating Margin | 22.76% |
| Pretax Margin | 25.48% |
| Profit Margin | 21.97% |
| EBITDA Margin | 27.43% |
| EBIT Margin | 22.76% |
| FCF Margin | 21.42% |
Dividends & Yields
This stock pays an annual dividend of 13.50, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | 13.50 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | 17.39% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 28.39% |
| Buyback Yield | 0.14% |
| Shareholder Yield | 0.88% |
| Earnings Yield | 2.55% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |